Search Results - "Farris, Carly M."
-
1
Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluid
Published in Nature protocols (01-04-2023)“…Misfolded alpha-synuclein (αSyn) aggregates are a hallmark event in Parkinson’s disease (PD) and other synucleinopathies. Recently, αSyn seed amplification…”
Get full text
Journal Article -
2
High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson's disease
Published in Acta neuropathologica communications (06-11-2021)“…Alpha-synuclein seed amplification assays (αSyn-SAAs) are promising diagnostic tools for Parkinson's disease (PD) and related synucleinopathies. They enable…”
Get full text
Journal Article -
3
Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assays
Published in Molecular neurodegeneration (01-04-2023)“…Aggregation of α-synuclein (α-syn) is a prominent feature of Parkinson's disease (PD) and other synucleinopathies. Currently, α-syn seed amplification assays…”
Get full text
Journal Article -
4
-
5
Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study
Published in Lancet neurology (01-05-2023)“…Emerging evidence shows that α-synuclein seed amplification assays (SAAs) have the potential to differentiate people with Parkinson's disease from healthy…”
Get full text
Journal Article -
6
Accurate Detection of α‐Synuclein Seeds in Cerebrospinal Fluid from Isolated Rapid Eye Movement Sleep Behavior Disorder and Patients with Parkinson's Disease in the DeNovo Parkinson (DeNoPa) Cohort
Published in Movement disorders (01-04-2023)“…ABSTRACT Background Misfolded α‐synuclein (αSyn) aggregates (αSyn‐seeds) in cerebrospinal fluid (CSF) are biomarkers for synucleinopathies such as Parkinson's…”
Get full text
Journal Article -
7
α‐Synuclein Seed Amplification in CSF and Brain from Patients with Different Brain Distributions of Pathological α‐Synuclein in the Context of Co‐Pathology and Non‐LBD Diagnoses
Published in Annals of neurology (01-10-2022)“…Objective The purpose of this study was to determine the sensitivity and specificity of α‐synuclein seed amplification assay (αSyn‐SAA) in antemortem and…”
Get full text
Journal Article -
8
α-Synuclein seed amplification assay as a diagnostic tool for parkinsonian disorders
Published in Parkinsonism & related disorders (01-12-2023)“…Synucleinopathies such as Parkinson's disease (PD) and multiple system atrophy (MSA) can be challenging to diagnose due to the symptom overlap with, for…”
Get full text
Journal Article -
9
Investigating alpha‐synuclein co‐pathology in Alzheimer's disease by means of cerebrospinal fluid alpha‐synuclein seed amplification assay
Published in Alzheimer's & dementia (01-04-2024)“…INTRODUCTION Lewy body disease, a frequently observed co‐pathology in Alzheimer's disease (AD), can be identified antemortem in cerebrospinal fluid (CSF) by…”
Get full text
Journal Article -
10
Seed Amplification Assay to Diagnose Early Parkinson's and Predict Dopaminergic Deficit Progression
Published in Movement disorders (01-10-2021)Get full text
Journal Article -
11
Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trial
Published in Nature medicine (01-09-2024)“…Investigational therapeutics that target toxic species of α-synuclein (αSyn) aim to slow down or halt disease progression in patients with Parkinson’s disease…”
Get full text
Journal Article -
12
Chemo-Mechanical Factors That Limit Cellular Force Generation
Published in Frontiers in physics (18-02-2022)“…Cellular traction forces that are dependent on actin-myosin activity are necessary for numerous developmental and physiological processes. As traction force…”
Get full text
Journal Article -
13
Accurate detection of α-Synuclein seeds in CSF from iRBD and Parkinson patients in the DeNoPa cohort
Published in Movement disorders (13-02-2023)Get full text
Journal Article -
14
Sensitivity and specificity of a seed amplification assay for diagnosis of multiple system atrophy: a multicentre cohort study
Published in Lancet neurology (01-12-2024)“…The pathological hallmarks of multiple system atrophy and Parkinson's disease are, respectively, misfolded-α-synuclein-laden glial cytoplasmic inclusions and…”
Get full text
Journal Article -
15
Cerebrospinal fluid lipoproteins inhibit [alpha]-synuclein aggregation by interacting with oligomeric species in seed amplification assays
Published in Molecular neurodegeneration (01-04-2023)“…Background Aggregation of [alpha]-synuclein ([alpha]-syn) is a prominent feature of Parkinson's disease (PD) and other synucleinopathies. Currently,…”
Get full text
Journal Article